Antioxidants and Redox Signaling · 2019 · 87 citations · 32 references
MedicinePathologyPharmacologyApoptosisImmunopathologyInflammationInflammation In Infectious DiseaseInnate Immune ModulationOxidative Stress In InflammationReactive Oxygen SpeciesRespiratory InfectionsRespiratory Infectious DiseasesAirway Inflammation ModulationInnate Immune EffectorsInnate Immune FunctionLung Immune ResponseMacrophage Reactive Oxygen Species ResponsesPulmonary Oxidative StressReactive Oxygen Species GenerationViral Respiratory Infections
Aims: Reactive oxygen species (ROS) are highly reactive molecules generated in different subcellular sites or compartments, including endosomes via the NOX2-containing nicotinamide adenine dinucleotide phosphate oxidase during an immune response and in mitochondria during cellular respiration. However, while endosomal NOX2 oxidase promotes innate inflammation to influenza A virus (IAV) infection, the role of mitochondrial ROS (mtROS) has not been comprehensively investigated in the context of viral infections in vivo . Results: In this study, we show that pharmacological inhibition of mtROS, with intranasal delivery of MitoTEMPO, resulted in a reduction in airway/lung inflammation, neutrophil infiltration, viral titers, as well as overall morbidity and mortality in mice infected with IAV (Hkx31, H3N2). MitoTEMPO treatment also attenuated apoptotic and necrotic neutrophils and macrophages in airway and lung tissue. At an early phase of influenza infection, that is, day 3 there were significantly lower amounts of IL-1β protein in the airways, but substantially higher amounts of type I IFN-β following MitoTEMPO treatment. Importantly, blocking mtROS did not appear to alter the initiation of an adaptive immune response by lung dendritic cells, nor did it affect lung B and T cell populations that participate in humoral and cellular immunity. Innovation/Conclusion: Influenza virus infection promotes mtROS production, which drives innate immune inflammation and this exacerbates viral pathogenesis. This pathogenic cascade highlights the therapeutic potential of local mtROS antioxidant delivery to alleviate influenza virus pathology.
32
Evanna L. Mills, Beth Kelly, Angela Logan et al. · Cell · 2016 · 2.2K citations · Full text
Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus
Terrence M. Tumpey, Christopher F. Basler, Patricia V. Aguilar et al. · Science · 2005 · 1.3K citations
Laura A. Sena, Sha Li, Amit Jairaman et al. · Immunity · 2013 · 1.3K citations · Full text